Literature DB >> 762593

Carnitine palmitoyltransferase II deficiency with normal carnitine palmitoyltransferase I in skeletal muscle and leucocytes.

H R Scholte, F G Jennekens, J J Bouvy.   

Abstract

Deficiency of carnitine palmitoyltransferase II (CPT II), was found to be the cause of the syndrome of muscle pain and myoglobinuria following strenuous exercise in an otherwise healthy young man. During fasting, serum creatine kinase remained low and ketogenesis was normal. The clearance of a fat emulsion and the activity of extrahepatic lipoprotein lipase was lowered, while the hepatic lipoprotein lipase was normal. A skeletal muscle biopsy did not show abnormal lipid storage. CPT II was deficient in skeletal muscle and leucocytes, while CPT I activity was normal and exhibited normal kinetic properties. CPT I has a higher affinity for palmitoylcarnitine than CPT II, and is more inhibited at increasing palmitoylcarnitine concentrations. In erythrocytes only CPT I is present.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 762593     DOI: 10.1016/0022-510x(79)90007-8

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  19 in total

1.  Broad specificity of carnitine palmitoyltransferase II towards long-chain acyl-CoA beta-oxidation intermediates and its practical approach to the synthesis of various long-chain acylcarnitines.

Authors:  F V Ventura; C G Costa; L IJlst; L Dorland; M Duran; C Jakobs; I T de Almeida; R J Wanders
Journal:  J Inherit Metab Dis       Date:  1997-07       Impact factor: 4.982

Review 2.  Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects.

Authors:  Stephanie E Reuter; Allan M Evans
Journal:  Clin Pharmacokinet       Date:  2012-09-01       Impact factor: 6.447

3.  High serum creatine kinase levels associated with cylindrical spirals at muscle biopsy.

Authors:  S Rapuzzi; A Prelle; M Moggio; C Rigoletto; P Ciscato; G Comi; F Francesca; G Scarlato
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

4.  The effect of malonyl-CoA on overt and latent carnitine acyltransferase activities in rat liver and adipocyte mitochondria.

Authors:  E D Saggerson; C A Carpenter
Journal:  Biochem J       Date:  1983-02-15       Impact factor: 3.857

5.  [Diagnostic significance of muscle biopsies in metabolic myopathies. II. Clinical biochemistry].

Authors:  T Deufel; I Paetzke; D Pongratz; G Hübner; O H Wieland
Journal:  Klin Wochenschr       Date:  1984-07-16

6.  Familial Leigh's syndrome: association with a defect in oxidative metabolism probably restricted to brain.

Authors:  P M van Erven; F J Gabreëls; W Ruitenbeek; W O Renier; K J Lamers; J L Sloof
Journal:  J Neurol       Date:  1987-05       Impact factor: 4.849

7.  Inhibition of carnitine palmitoyltransferase in normal human skeletal muscle and in muscle of patients with carnitine palmitoyltransferase deficiency by long- and short-chain acylcarnitine and acyl-coenzyme A.

Authors:  S Zierz; S Neumann-Schmidt; F Jerusalem
Journal:  Clin Investig       Date:  1993-10

8.  Fatal lipid storage myopathy with deficiency of cytochrome-c-oxidase and carnitine. A contribution to the combined cytochemical-finestructural identification of cytochrome-c-oxidase in longterm frozen muscle.

Authors:  J Müller-Höcker; D Pongratz; T Deufel; J M Trijbels; W Endres; G Hübner
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1983

9.  Myoglobinuria in carnitine palmityltransferase deficiency.

Authors:  D Rowett
Journal:  Int Urol Nephrol       Date:  1982       Impact factor: 2.370

10.  Exertional rhabdomyolysis in a patient with calcium adenosine triphosphatase deficiency.

Authors:  P J Poels; R A Wevers; J P Braakhekke; A A Benders; J H Veerkamp; E M Joosten
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-07       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.